Novo gets FDA warning letter at troubled Indiana site formerly owned by Catalent

16th December 2025 Uncategorised 0

Novo Nordisk, which has stumbled through a bit of a manufacturing hangover at a former Catalent production site it picked up last year, was hit with a warning letter from the FDA.

More: Novo gets FDA warning letter at troubled Indiana site formerly owned by Catalent
Source: fierce